Compound ID | 1862
Synonym(s): ICI 194,660 | SM-7338 | SM7338 | SM 7338
Class: Beta-lactam (carbapenem)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Carbapenems bind to all PBPs, with PBP2 and PBP4 as the highest-affinity targets.Carbapenems have a very broad spectrum incl. non-fermenters and are not hydrolysed by most beta-lactamases with exception of carbapenemases |
Description: | Semisynthetic, derived from thienamycin. Fixed combinations with various beta-lactamase inhibitors |
Institute where first reported: | Pfizer |
Year first mentioned: | 1983 |
Highest developmental phase: | Approved by FDA in 1996 |
Development status: | Approved, off-patent |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/441130 |
Guide to Pharmacology: | meropenem |
Citations: |
|